John Trizzino, EVP, Chief Commercial Officer at NOVAVAX INC (NVAX), sold 73 shares at $128.60 ($9K) on 2021-01-25, disclosed to the SEC on 2021-01-27.
Scheduled sale ($9k) by EVP, Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| NVAX | SELL | 2021-09-22 | $6.8M | — | Filing → |
| NVAX | SELL | 2021-09-15 | $7.0M | — | Filing → |
| NVAX | SELL | 2021-05-07 | $802K | — | Filing → |